Skip to content

Tag Archives: safety

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in…

ABSTRACT Aims  Clinical trials test the safety and efficacy of behavioral and pharmacological interventions in drug-dependent individuals. However, there is no consensus about the most appropriate outcome(s) to consider in determining treatment efficacy or on the most appropriate methods for assessing selected outcome(s)

New dissolvable tobacco products discussed at FDA hearing

This week, ACSH’s Jody Manley and Dr. Gilbert Ross sat in on the Tobacco Products Scientific Advisory Committee’s (TPSAC) preliminary hearing on the safety of dissolvable tobacco products such as RJ Reynold’s Camel Orbs lozenges and Altria’s dissolvable tobacco sticks. . .

Just Two Talks With Teens Can Reduce Marijuana Use For At Least A Year

Nearly a third of high school students in the United States report smoking marijuana. Despite the mixed messages about the safety of marijuana, smoking grass is risky behavior for teens, who are, after all, still developing…

Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy

ABSTRACT Aims.  To assess the profile, utilization patterns, satisfaction and perceived effects among users of electronic cigarettes ( e-cigarettes ). Design and Setting.  Internet survey in English and French in 2010. Participants.  Visitors of websites and online discussion forums dedicated to e-cigarettes and to smoking cessation

Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply

Abstract: Background: Drug scenes within several countries have changed in recent years to incorporate a range of licit psychoactive products, collectively known as “legal highs.” Hundreds of different legal high products have been described in the literature. Many of these products contain synthetic stimulants that allegedly “mirror” the effects of some illicit drugs.

STIER: Want to Quit Smoking? FDA regulations make it harder to do

The FDA and groups such as the Campaign for Tobacco-Free Kids oppose the use of “tobacco harm reduction,” which is the use of less harmful products than cigarettes to help people quit smoking. Late last year, the FDA warned about the safety of electronic or E-cigarettes and began a campaign to keep them away from smokers. E-cigarettes not only supply “clean” nicotine, but also look like cigarettes — many even have an LED light at the tip.

E-cigs less dangerous than traditional cigarettes, researcher claims

In a new report that bucks the concerns raised by the Food and Drug Administration, a Boston University School of Public Health (BUSPH) researcher concludes that electronic cigarettes are much safer than real cigarettes and show promise in the fight against tobacco-related diseases and death. The review, which will be published online ahead of print this month in the Journal of Public Health Policy, is the first to comprehensively examine scientific evidence about the safety and effectiveness of electronic cigarettes, also known as e-cigarettes, said Michael Siegel, professor of community health sciences at BUSPH.

Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes

The issue of harm reduction has long been controversial in the public health practice of tobacco control. Health advocates have been reluctant to endorse a harm reduction approach out of fear that tobacco companies cannot be trusted to produce and market products that will reduce the risks associated with tobacco use. Recently, companies independent of the tobacco industry introduced electronic cigarettes, devices that deliver vaporized nicotine without combusting tobacco.

e-Cigarettes Warning: Safety Evaluation Urgently Needed, Researchers Say

researchers at the University of California, Riverside evaluated five e-cigarette brands and found design flaws, lack of adequate labeling, and several concerns about quality control and health issues.

Drug-maker asks FDA to stop RJR test-market sales : Orbs, Sticks, Strips products currently under review by advisory committee

The battle lines are being drawn over the marketplace potential of smokeless tobacco products. The consumer health-care division of GlaxoSmithKline (GSK) — one of the world’s largest pharmaceutical companies — fired a salvo last week across the bow of R.J